Free Trial
→ I'm handing you this one free (From Behind the Markets) (Ad)tc pixel Free SBFMW Stock Alerts

Sunshine Biopharma (SBFMW) Competitors

Sunshine Biopharma logo
$0.03 0.00 (0.00%)
As of 11/13/2026
Compare

SBFMW vs. SXTPW, ADTX, BFRIW, CALA, and CINGW

Should you buy Sunshine Biopharma stock or one of its competitors? Sunshine Biopharma's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Aditxt (ADTX), Biofrontera (BFRIW), Calithera Biosciences (CALA), and Cingulate (CINGW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Sunshine Biopharma compare to 60 Degrees Pharmaceuticals?

Sunshine Biopharma (NASDAQ:SBFMW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.35MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

In the previous week, Sunshine Biopharma had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for Sunshine Biopharma and 1 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.82 beat Sunshine Biopharma's score of 0.93 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Sunshine Biopharma Positive
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

Sunshine Biopharma beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Aditxt?

Aditxt (NASDAQ:ADTX) and Sunshine Biopharma (NASDAQ:SBFMW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Sunshine Biopharma has higher revenue and earnings than Aditxt.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aditxt$14.34K0.02-$41.71M-$100.79 thousandN/A
Sunshine Biopharma$35.35MN/AN/AN/AN/A

15.5% of Aditxt shares are held by institutional investors. 0.0% of Aditxt shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aditxt
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sunshine Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Sunshine Biopharma had 2 more articles in the media than Aditxt. MarketBeat recorded 2 mentions for Sunshine Biopharma and 0 mentions for Aditxt. Sunshine Biopharma's average media sentiment score of 0.93 beat Aditxt's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
Aditxt Neutral
Sunshine Biopharma Positive

Sunshine Biopharma has a net margin of 0.00% compared to Aditxt's net margin of -360,152.50%. Sunshine Biopharma's return on equity of 0.00% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
Aditxt-360,152.50% -374.60% -105.93%
Sunshine Biopharma N/A N/A N/A

Summary

Sunshine Biopharma beats Aditxt on 6 of the 9 factors compared between the two stocks.

How does Sunshine Biopharma compare to Biofrontera?

Sunshine Biopharma (NASDAQ:SBFMW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.

In the previous week, Biofrontera had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 3 mentions for Biofrontera and 2 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 0.93 beat Biofrontera's score of 0.93 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sunshine Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Biofrontera
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.35MN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

Summary

Biofrontera beats Sunshine Biopharma on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Calithera Biosciences?

Sunshine Biopharma (NASDAQ:SBFMW) and Calithera Biosciences (OTCMKTS:CALA) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Calithera Biosciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.35MN/AN/AN/AN/A
Calithera BiosciencesN/AN/AN/AN/AN/A

In the previous week, Sunshine Biopharma had 2 more articles in the media than Calithera Biosciences. MarketBeat recorded 2 mentions for Sunshine Biopharma and 0 mentions for Calithera Biosciences. Sunshine Biopharma's average media sentiment score of 0.93 beat Calithera Biosciences' score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Positive
Calithera Biosciences Neutral

Summary

Sunshine Biopharma beats Calithera Biosciences on 3 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Cingulate?

Sunshine Biopharma (NASDAQ:SBFMW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.35MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Sunshine Biopharma had 1 more articles in the media than Cingulate. MarketBeat recorded 2 mentions for Sunshine Biopharma and 1 mentions for Cingulate. Cingulate's average media sentiment score of 1.82 beat Sunshine Biopharma's score of 0.93 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Sunshine Biopharma Positive
Cingulate Very Positive

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Sunshine Biopharma beats Cingulate on 2 of the 3 factors compared between the two stocks.

Get Sunshine Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBFMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBFMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBFMW vs. The Competition

Export
MetricSunshine BiopharmaPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$13.80B$7.87B$12.20B
Dividend YieldN/A2.56%2.46%4.53%
P/E RatioN/A29.2934.5630.66
Price / SalesN/A7.338.685.86
Price / CashN/A15.7421.9322.49
Price / BookN/A4.934.353.76
Net IncomeN/A$2.89B$3.52B$390.95M
7 Day PerformanceN/A-0.38%-1.52%-0.34%
1 Month PerformanceN/A-3.22%-3.54%-5.79%
1 Year PerformanceN/A-5.98%1.45%-5.71%

Sunshine Biopharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBFMW
Sunshine Biopharma
N/A$0.03
flat		N/AN/A$0.00$35.35MN/A50
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/AN/A$0.00$1.11MN/A3
ADTX
Aditxt
0.0236 of 5 stars		$0.00
-20.0%		N/AN/A$0.00$14.34KN/A26
BFRIW
Biofrontera
N/A$0.00
flat		N/AN/A$0.00$46.18MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SBFMW) was last updated on 11/15/2026 by MarketBeat.com Staff.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel